Not for release, publication or distribution in whole or in part in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

LONDON, March 6, 2026 /PRNewswire/ -- Athora Holding Ltd. ("Athora" or "the Group"), a leading European savings and retirement services group, today announced that it has secured €3.5 billion of common equity commitments from a broad base of investors. The investors include sovereign wealth funds – such as Mubadala Investment Company ("Mubadala") and Abu Dhabi Investment Council (a fund wholly owned by Mubadala) which represent the largest new investors in this issuance. In addition, the issuance attracted pension funds, insurance companies and other cornerstone investors, including Apollo and Athene.

Since inception in 2018, Athora has secured approximately €9 billion of common equity commitments from a high-quality, institutional investor base, operating with a long-time horizon that is well matched to long-term savings and retirement customer commitments. This is the largest amount of common equity raised by any European insurance company (or dedicated insurance vehicle) in the past decade.

The majority of the issuance proceeds will be used to fund the acquisition of Pension Insurance Corporation Group Limited ("PICG"), alongside remaining equity commitments from Athora's 2022 equity raise. The residual issuance proceeds will be used to fund broader long-term growth opportunities across the Group, including Pension Risk Transfers ("PRT") in the Netherlands.

Regulatory approval for Athora's acquisition of PICG, including its wholly owned subsidiary, Pension Insurance Corporation plc ("PIC") was received today, 6 March from the Prudential Regulation Authority ("PRA"), in consultation with the Financial Conduct Authority ("FCA"). In keeping with the transaction terms, Athora, PIC and the selling shareholders are now progressing towards expected completion on or around 27 March 2026.

Mike Wells, Group CEO of Athora said:

"I am delighted to announce the close of Athora's latest capital raise, bringing the total amount of common equity commitments raised by Athora to approximately €9 billion. Proceeds from the issuance will support our target funding structure for the PICG acquisition, which received regulatory approval today and is expected to complete on or around 27 March 2026.

I would like to thank Athora's existing and new investors for their continued support and endorsement of our strategic vision. The proceeds will enable Athora to deliver a scaled entry into the attractive UK pensions market, expand PIC's capacity to serve trustees seeking to secure pension risk transfer solutions, while providing the resources to support other ongoing growth initiatives across Europe."

This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in any jurisdiction.

About Athora

Athora is a leading European savings and retirement services group. We concentrate on the large and attractive traditional life and pensions market, with an ambition to become a leading provider of guaranteed savings and pensions products in Europe. We serve the needs of individual and corporate customers who continue to demand products offering safety of returns. Athora's principal subsidiaries are Athora Netherlands N.V. (Amsterdam, Netherlands), Athora Belgium S.A. (Brussels, Belgium), Athora Lebensversicherung AG (Wiesbaden, Germany), Athora Italia S.p.A (Genoa and Milan, Italy) and Athora Life Re Ltd. (Bermuda). At 30 June 2025, Athora had AuMA of €76.4 billion, c.1,430 employees and approx. 2.8 million customers. For more information, please visit: www.athora.com LinkedIn: www.linkedin.com/company/athoragroup

Disclaimer

Certain information contained herein may be "forward-looking" in nature. Due to various risks and uncertainties, actual events or results or actual performance may differ materially from those reflected or contemplated in such forward-looking information. As such, undue reliance should not be placed on such information. Forward-looking statements may be identified by the use of terminology including, but not limited to, "may," "will," "should," "expect," "anticipate," "target," "project," "estimate," "intend," "continue" or "believe" or the negatives thereof or other variations thereon or comparable terminology.

Logo - https://mma.prnewswire.com/media/2927607/Athora_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/athora-holding-ltd-secures-3-5-billion-of-common-equity-commitments-and-receives-regulatory-approval-for-pension-insurance-corporation-group-limited-acquisition-302706633.html

In Deutschland ist die Zahl der Organspender im vergangenen Jahr leicht gestiegen – der Bedarf bleibt jedoch deutlich höher. Nach Angaben der Deutschen Stiftung Organtransplantation (DSO) haben 985 Menschen nach ihrem Tod ein oder mehrere Organe gespendet, ein Plus von 3,4 Prozent im Vergleich zum Vorjahr. Insgesamt wurden damit mehr als 3.000 Organe übertragen. Gleichzeitig stehen laut DSO rund 8.200 Patientinnen und Patienten auf den Wartelisten und warten oft vergeblich auf ein Spenderorgan.

Die DSO und die Landesärztekammer Hessen nehmen diese Diskrepanz zum Anlass, in einer Veranstaltung in Frankfurt die Wirkung von Organspenden sichtbar zu machen. Empfängerinnen und Empfänger schildern dort, wie Transplantationen ihr Leben verändert haben, Angehörige berichten, wie sie die Entscheidung zur Spende getroffen haben. Ziel ist es, die abstrakte Statistik mit persönlichen Erfahrungen zu verbinden – und damit mehr Menschen zu motivieren, sich frühzeitig mit der eigenen Haltung zur Organspende zu beschäftigen und diese zu dokumentieren.

Ein Beispiel dafür ist Lea Jantschke. Ihre Mutter starb 2020 plötzlich an einem Hirnaneurysma, die Familie entschied sich zur Organspende. Ein Jahr später erhielt Jantschke den ersten Brief eines Empfängers der Niere ihrer Mutter. Der Kontakt erfolgt anonym, doch der emotionale Effekt ist für die Angehörigen groß. Der Brief sei für sie „wie ein kleiner Gruß“ von der Mutter gewesen, sagt die 27-Jährige. Das Schreiben habe ihrer Familie in der Trauerphase Halt gegeben, der Gedanke, die Mutter sei nun „ein Teil von dieser Familie“, habe sie besonders berührt.

Gleichzeitig macht die DSO deutlich, wie hoch der Druck auf Angehörige ist, wenn keine dokumentierte Entscheidung des Verstorbenen vorliegt. In den meisten Fällen hätten sich Betroffene zu Lebzeiten nicht mit dem Thema Organspende auseinandergesetzt, erläutert die Stiftung. Dann müssen Angehörige in einer emotionalen Ausnahmesituation und unter Zeitdruck entscheiden – häufig mit dem Ergebnis, dass sie eine Spende ablehnen, weil der Wille der verstorbenen Person nicht bekannt ist. Ärztliche Vertreter der DSO werben deshalb nachdrücklich dafür, den eigenen Standpunkt zur Organspende zu Lebzeiten festzuhalten, um sowohl Wartende auf ein Organ als auch die eigenen Angehörigen zu entlasten.